Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1027 of 6351
-
Immunotherapy drug durvalumab tested to stop bladder cancer return
Disease control OngoingThe purpose of this study is to find out what effects durvalumab has on bladder cancer, combined with treatment after completion of surgery, chemotherapy and radiotherapy.
Phase 2 • Sponsor: Canadian Cancer Trials Group • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New shingles vaccine trial aims to protect vulnerable kids
Vaccine Recruiting nowThe purpose of this study is to evaluate the reactogenicity, safety and immunogenicity of 2 doses of PED-HZ/su, GSK's vaccine candidate for the prevention of Herpes Zoster (HZ) in immunocompromised paediatric renal transplant recipients aged 1-17 years
Phase 1/2 • Sponsor: GlaxoSmithKline • Aim: Vaccine
Last updated Jun 27, 2026 09:08 UTC
-
New hope for High-Risk blood cancer patients: ruxolitinib trial launches
Disease control Recruiting nowThe trial will be a phase III, randomised-controlled, multi-centre, international, open-label trial consisting of ruxolitinib versus best available therapy, where best available therapy is a choice of interferon alpha, any formulation permitted (IFN) or hydroxycarbamide (HC), and…
Phase 3 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Brain scans may reveal if magnetic therapy hits the right spot for depression
Knowledge-focused CompletedThis study investigates how brains change as a result of a treatment for depression called repetitive transcranial magnetic stimulation (rTMS). People who receive rTMS will have pictures of their brains and brain activity taken by a magnetic resonance imaging (MRI) scanner before…
Sponsor: VA Office of Research and Development • Aim: Knowledge-focused
Last updated Aug 05, 2026 00:00 UTC
-
Second chance: stem cell transplant trial aims to rescue failing sickle cell treatments
Disease control Recruiting nowBackground: Sickle cell disease can often be treated with blood stem cell transplants. But for some people the disease returns. This study will give a second transplant to people whose disease has returned but still have some donor cells in their body. Objective: To cure peopl…
Phase 1/2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New mammogram technique could spot breast cancer earlier in survivors
Diagnosis OngoingThis is a prospective clinical trial that will examine if contrast-enhanced mammography substantially improves breast cancer detection compared to mammography with tomosynthesis, with minimal increase in false-positives, in women with a personal history of breast cancer.
Sponsor: Wendie Berg • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Could a virtual life-coach program help young adults tame type 1 diabetes?
Disease control CompletedThis study will evaluate (1) the efficacy of REAL-T, a lifestyle-based telehealth intervention, in improving glycemic control (HbA1c) and psychosocial outcomes, (2) which effects are retained over a 6-month follow-up period, and (3) the mediating mechanisms responsible for the in…
Sponsor: University of Southern California • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New drug cocktail shows promise against tough blood cancers
Disease control Recruiting nowThis phase I/II trial studies the side effects and how well cladribine, idarubicin, cytarabine, and quizartinib work in treating patients with acute myeloid leukemia or high-risk myelodysplastic syndrome that is newly diagnosed, has come back (relapsed), or does not respond to tr…
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
MRI-Guided radiation aims to hit tumors harder, spare healthy tissue
Disease control Recruiting nowThis is a master prospective Phase I-II trial evaluating feasibility and efficacy of stereotactic magnetic resonance (MR) guided adaptive radiation therapy (SMART) in patients with cancer. * The phase 1 study will evaluate the feasibility and safety of delivering SMART in patien…
Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Experimental vaccine aims to boost immune attack on Hard-to-Treat cancers
Disease control OngoingRef: Protocol Version 9.1 05 December 2024. NOUS-209-01 is a multicenter, open-label, multiple cohorts, clinical study, designed to evaluate safety, tolerability, and immunogenicity, and to detect any preliminary evidence of anti-tumor activity of Nous-209 genetic polyvalent vacc…
Phase 1/2 • Sponsor: Nouscom SRL • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New hope for kids with gigantism: daily shot may tame growth hormone
Disease control CompletedBackground: For children with gigantism, too much growth hormone (GH) in the body causes abnormal growth and many other problems. Current treatments often don t work; no medical treatment is approved by FDA. Researchers want to see if the drug pegvisomant can help. Objective: …
Phase 3 • Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug shows promise in preventing deadly blood clot relapses in japanese patients
Disease control CompletedPrimary Objective: To evaluate the effect of caplacizumab on prevention of recurrence of aTTP (proportion of participants with a recurrence of aTTP) during the overall study period. Secondary Objectives: * To evaluate effect of caplacizumab on * prevention of recurrence of …
Phase 2/3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
DNA vaccines join forces with keytruda to fight Hard-to-Treat prostate cancer
Disease control OngoingThis trial will evaluate the use of one versus two DNA vaccines, delivered concurrently with PD-1 blockade using pembrolizumab followed by treatment with pembrolizumab alone, and delivered over a prolonged period of time (for a maximum of 2 years (32 cycles) or until radiographic…
Phase 2 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
New rabies vaccine shows promise in large trial
Prevention CompletedThe primary objective of this study is: To demonstrate the VRVg-2 is non-inferior to Verorab and Imovax Rabies vaccines in each age group (pediatric and adult populations) when administered as a 3-dose PrEP regimen, in terms of proportion of participants achieving a rabies virus…
Phase 3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Prevention
Last updated Jun 27, 2026 09:03 UTC
-
New light therapy aims to halt cornea disease and save sight
Disease control Recruiting nowTo evaluate the safety and effectiveness of the PXL Platinum 330 system for performing corneal cross-linking (CXL) for the treatment of ectatic disorders.
Phase 2 • Sponsor: Goodman Eye Center • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New hope for teens with MS: drug trial aims to cut relapses
Disease control OngoingThis study will evaluate the safety, tolerability, and descriptive efficacy of BIIB017 in pediatric participants with relapsing-remitting multiple sclerosis (RRMS) and to assess the pharmacokinetics (PK) of BIIB017 in pediatric participants with RRMS in Part 1. In Part 2, the stu…
Phase 3 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 26, 2026 15:45 UTC
-
150,000 people tracked to see if At-Home stool test can slash colon cancer deaths
Diagnosis OngoingThe purpose of this study is to gather information about the long term health of people who have been prescribed the Cologuard test, which is used for colorectal cancer (CRC) screening.
Sponsor: Exact Sciences Corporation • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
Gene-Guided drugs aim to shrink brain tumors
Disease control OngoingThis phase II trial studies how well genetic testing works in guiding treatment for patients with solid tumors that have spread to the brain. Several genes have been found to be altered or mutated in brain metastases such as NTRK, ROS1, CDK, PI3K, or KRAS G12C. Medications that t…
Phase 2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Heated chemo plus immunotherapy shows promise for tough ovarian cancers
Disease control CompletedSpread pattern, the lack of alternative treatments, and emerging data on the activity of anti-Programmed death ligand 1 (PDL1) targeted checkpoint inhibitor therapy in gynecological cancers provide the rationale for this investigation. Surgery and Hyperthermic Intraperitoneal Ch…
Phase 1/2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New hope for kids with eye inflammation: baricitinib trial shows promise
Disease control OngoingThe reason for this study is to see if the study drug baricitinib given orally is safe and effective in participants with active juvenile idiopathic arthritis (JIA)-associated uveitis or chronic anterior antinuclear antibody-positive uveitis from 2 years to less than 18 years old…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC